Witold Lasek

1.9k total citations
50 papers, 1.4k citations indexed

About

Witold Lasek is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Witold Lasek has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 20 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Witold Lasek's work include Immunotherapy and Immune Responses (18 papers), Immune Cell Function and Interaction (16 papers) and CAR-T cell therapy research (7 papers). Witold Lasek is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Immune Cell Function and Interaction (16 papers) and CAR-T cell therapy research (7 papers). Witold Lasek collaborates with scholars based in Poland, United States and Italy. Witold Lasek's co-authors include Marek Jakóbisiak, Radosław Zagożdżon, Jakub Gołąb, Wojciech Feleszko, Tomasz Stokłosa, Adam Giermasz, Tomasz Świtaj, Łukasz Zapała, Rafał Kamiński and Piotr J. Wysocki and has published in prestigious journals such as Blood, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Witold Lasek

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Witold Lasek Poland 19 675 564 415 161 152 50 1.4k
Kevin Van der Jeught Belgium 16 489 0.7× 536 1.0× 700 1.7× 198 1.2× 97 0.6× 23 1.3k
María Paula Roberti France 8 559 0.8× 828 1.5× 604 1.5× 162 1.0× 64 0.4× 11 1.4k
Ignacio Algarra Spain 24 1.5k 2.2× 971 1.7× 531 1.3× 191 1.2× 111 0.7× 53 2.3k
Maria Rosaria Ruocco Italy 25 472 0.7× 515 0.9× 886 2.1× 330 2.0× 102 0.7× 51 1.8k
Afshin Namdar Canada 23 586 0.9× 410 0.7× 665 1.6× 282 1.8× 65 0.4× 31 1.5k
Arvinder Kapur United States 20 531 0.8× 333 0.6× 862 2.1× 263 1.6× 82 0.5× 39 1.6k
M. Jane Ehrke United States 22 713 1.1× 539 1.0× 478 1.2× 97 0.6× 64 0.4× 69 1.5k
Ángel M. García‐Lora Spain 27 1.6k 2.4× 1.2k 2.1× 699 1.7× 171 1.1× 158 1.0× 57 2.5k
Yao Yao China 25 731 1.1× 1.1k 1.9× 825 2.0× 227 1.4× 183 1.2× 83 2.2k
O. Graciela Scharovsky Argentina 19 321 0.5× 479 0.8× 370 0.9× 221 1.4× 69 0.5× 52 1.1k

Countries citing papers authored by Witold Lasek

Since Specialization
Citations

This map shows the geographic impact of Witold Lasek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Witold Lasek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Witold Lasek more than expected).

Fields of papers citing papers by Witold Lasek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Witold Lasek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Witold Lasek. The network helps show where Witold Lasek may publish in the future.

Co-authorship network of co-authors of Witold Lasek

This figure shows the co-authorship network connecting the top 25 collaborators of Witold Lasek. A scholar is included among the top collaborators of Witold Lasek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Witold Lasek. Witold Lasek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lasek, Witold. (2022). Cancer immunoediting hypothesis: history, clinical implications and controversies. Central European Journal of Immunology. 47(2). 168–174. 15 indexed citations
2.
Kaleta, Beata, et al.. (2020). Comparative Study of Immunomodulatory Agents to Induce Human T Regulatory (Treg) Cells: Preferential Treg-Stimulatory Effect of Prednisolone and Rapamycin. Archivum Immunologiae et Therapiae Experimentalis. 68(4). 20–20. 15 indexed citations
3.
Majewska, Anna, et al.. (2016). Inhibition of adenovirus multiplication by inosine pranobex and interferon α <i>in vitro</i>. Central European Journal of Immunology. 40(4). 395–399. 9 indexed citations
4.
Majewska, Anna, Witold Lasek, & G. Młynarczyk. (2015). [Inosine pranobex - cytotoxic activities and effect of on replication of human parainfluenza viruses (HPIV-2, HPIV-4), entroviruses (CA16, EV71) and adenoviruses (HAdV-2, HAdV-5) in vitro].. PubMed. 67(2). 107–13. 4 indexed citations
5.
Lasek, Witold, Radosław Zagożdżon, & Marek Jakóbisiak. (2014). Interleukin 12: still a promising candidate for tumor immunotherapy?. Cancer Immunology Immunotherapy. 63(5). 419–435. 384 indexed citations
6.
Sieńko, Jacek, et al.. (2012). Synergistic cytotoxic effect of sulindac and pyrrolidine dithiocarbamate against ovarian cancer cells. Oncology Reports. 27(4). 1245–1250. 4 indexed citations
7.
Jakóbisiak, Marek, Jakub Gołąb, & Witold Lasek. (2011). Interleukin 15 as a promising candidate for tumor immunotherapy. Cytokine & Growth Factor Reviews. 22(2). 99–108. 98 indexed citations
8.
Sieńko, Jacek, et al.. (2011). [Antitumor effects of sulindac in ovarian cell cultures].. PubMed. 82(3). 195–9. 5 indexed citations
9.
Drela, Nadzieja, Ahmad Jalili, Rafał Kamiński, et al.. (2004). Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice. Cancer Immunology Immunotherapy. 53(4). 363–372. 40 indexed citations
10.
Jakóbisiak, Marek, Witold Lasek, & Jakub Gołąb. (2003). Natural mechanisms protecting against cancer. Immunology Letters. 90(2-3). 103–122. 142 indexed citations
11.
Lasek, Witold, Tomasz Świtaj, Jacek Sieńko, et al.. (2002). Stimulation of TNF-α production by 2-(1-adamantylamino)-6-methylpyridine (AdAMP) - a novel immunomodulator with potential application in tumour immunotherapy. Cancer Chemotherapy and Pharmacology. 50(3). 213–222. 4 indexed citations
12.
Feleszko, Wojciech, Izabela Młynarczuk-Biały, Ahmad Jalili, et al.. (2002). Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis‐dependent mechanism. International Journal of Cancer. 100(1). 111–118. 69 indexed citations
13.
Gołąb, Jakub, Katarzyna Kozar, Rafał Kamiński, et al.. (2000). Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice. Life Sciences. 66(13). 1223–1230. 12 indexed citations
14.
Lasek, Witold, Andrzej Maćkiewicz, Anna Czajka, et al.. (2000). Antitumor effects of the combination therapy with TNF-α gene–modified tumor cells and interleukin 12 in a melanoma model in mice. Cancer Gene Therapy. 7(12). 1581–1590. 25 indexed citations
15.
Stokłosa, Tomasz, Radosław Zagożdżon, Adam Giermasz, et al.. (1998). G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in mice. Annals of Oncology. 9(1). 63–69. 24 indexed citations
16.
Feleszko, Wojciech, et al.. (1998). Granulocyte-Macrophage Colony-Stimulating Factor Potentiates Antitumor Activity of Interleukin-12 in Melanoma Model in Mice. Tumor Biology. 19(2). 77–87. 6 indexed citations
17.
Zagożdżon, Radosław, Jakub Gołąb, Tomasz Stokłosa, et al.. (1998). Effective chemo-immunotherapy of L1210 leukemiain vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin. International Journal of Cancer. 77(5). 720–727. 32 indexed citations
18.
Feleszko, Wojciech, et al.. (1996). Granulocyte-macrophage colony-stimulating factor accelerates growth of Lewis lung carcinoma in mice. Cancer Letters. 101(2). 193–197. 4 indexed citations
19.
Lasek, Witold, Adam Giermasz, Wojciech Feleszko, et al.. (1996). Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor α in mice: Correlation betweenin vitro andin vivo results. International Journal of Cancer. 66(3). 374–379. 22 indexed citations
20.
Lasek, Witold, et al.. (1995). Potentiation of antitumor effects of tumor necrosis factor α and interferon γ by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice. Cancer Immunology Immunotherapy. 40(5). 315–321. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin Van der Jeught Breakdown of academic impact, for papers by María Paula Roberti Breakdown of academic impact, for papers by Ignacio Algarra Breakdown of academic impact, for papers by Maria Rosaria Ruocco Breakdown of academic impact, for papers by Afshin Namdar Breakdown of academic impact, for papers by Arvinder Kapur Breakdown of academic impact, for papers by M. Jane Ehrke Breakdown of academic impact, for papers by Ángel M. García‐Lora Breakdown of academic impact, for papers by Yao Yao Breakdown of academic impact, for papers by O. Graciela Scharovsky
Rankless by CCL
2026